Latest studies have shown that butyrylcholinesterase (BuChE) inhibitors or double acetyl and butyryl cholinesterase inhibitors exhibit enhanced restorative effects on AD with less side effects than specific AChE inhibitors [108]. The gene discussed is ACHE; the disease is Alzheimer disease.